Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
16.97
-0.89 (-4.98%)
Apr 3, 2025, 4:00 PM EDT - Market closed

Dianthus Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
22.79132.3315.377.64
Short-Term Investments
252.4541.3960.13-
Cash & Short-Term Investments
275.24173.7275.497.64
Cash Growth
58.44%130.12%888.35%-
Receivables
0.810.485.641.48
Inventory
3.042.160.820.24
Prepaid Expenses
1.471.10.090.02
Other Current Assets
0.36--0.01
Total Current Assets
280.9177.4582.039.39
Property, Plant & Equipment
1.750.80.960.03
Long-Term Investments
81.73---
Other Long-Term Assets
9.631.150.120.03
Total Assets
374.01179.4183.119.45
Accounts Payable
4.582.611.171.36
Accrued Expenses
13.076.56.613.99
Current Portion of Leases
0.320.420.35-
Current Unearned Revenue
0.480.10.1-
Total Current Liabilities
18.459.638.235.35
Long-Term Leases
1.170.170.44-
Long-Term Unearned Revenue
1.910.740.79-
Total Liabilities
21.5310.549.455.35
Common Stock
0.030.02--
Additional Paid-In Capital
526.73258.231.660.14
Retained Earnings
-174.39-89.42-45.87-17.39
Comprehensive Income & Other
0.110.05-0.16-
Total Common Equity
352.48168.87-44.37-17.25
Shareholders' Equity
352.48168.8773.664.1
Total Liabilities & Equity
374.01179.4183.119.45
Total Debt
1.490.590.79-
Net Cash (Debt)
355.48173.1374.77.64
Net Cash Growth
105.32%131.76%878.03%-
Net Cash Per Share
10.6733.6085.451.91
Filing Date Shares Outstanding
32.1329.354.014.01
Total Common Shares Outstanding
31.1214.824.014.01
Working Capital
262.45167.8273.814.04
Book Value Per Share
11.3311.40-11.05-4.31
Tangible Book Value
352.48168.87-44.37-17.25
Tangible Book Value Per Share
11.3311.40-11.05-4.31
Machinery
0.390.280.17-
Construction In Progress
---0.03
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q